Sep 15, 2012 · Conclusions: RSI is validated in 2 independent breast cancer datasets totaling 503 patients. Including prior data, RSI is validated in 5 ...
An accurate radiosensitivity molecular signature may lead to the refinement of treatment decision algorithms in breast cancer, to novel paradigms to test in ...
Sep 15, 2012 · Abstract. Purpose: Previously, we developed a radiosensitivity molecular signature [radiosensitivity index (RSI)].
Feb 13, 2018 · Recently, we developed RSI, a clinically-validated molecular signature that estimates tumor radiosensitivity.
Abstract Purpose: Previously, we developed a radiosensitivity molecular signature [radiosensitivity index (RSI)] that was clinically validated in 3 ...
We have demonstrated that combining a novel molecular signature of radiosensitivity (RSI) with the molecular subtypes further defines LR risk in breast cancer.
People also ask
What is the EMT signature for breast cancer?
Is breast cancer radiosensitive?
What is the molecular diagnostic test for breast cancer?
What are radiation marks for breast cancer?
Request PDF | On Jan 1, 2013, F. van der Leij and others published Validation of a Radiosensitivity Molecular Signature in Breast Cancer: Eschrich SA, ...
Jul 4, 2018 · This study presents the development and validation of a targeted gene expression assay to predict the risk of ipsilateral breast tumor ...
Nov 1, 2015 · Recently, we developed radiosensitivity (RSI), a clinically validated molecular signature that estimates tumor radiosensitivity.
Missing: Validation | Show results with:Validation
This signature was trained and validated in a separate human breast tumor datasets containing early stage patients treated with surgery and RT alone (no ...